相关实验视频

Updated: Jun 28, 2025

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

在COVID-19后肌底炎中的血酶:一个病例报告

Witoon Mitarnun¹, Lisa Kongngern¹, Praewa Tantisungvarakoon²

¹Neurology Unit, Department of Internal Medicine, Buriram Hospital, Buriram, Thailand

Qatar medical journal

|April 24, 2024

概括

血酶在治疗冠状病毒疾病2019 (COVID-19) 感染后的髓炎方面表现有前途. 这种治疗改善了一名长期患有COVID-19后脊髓炎的接种疫苗的患者的神经症状.

科学领域:

神经学神经学
传染性疾病传染性疾病
免疫学免疫学免疫学

背景情况:

神经系统并发症,包括骨髓炎,可能由冠状病毒疾病2019 (COVID-19) 引起.
有限的数据存在于后COVID-19脑膜炎的有效治疗方法.
骨髓炎是一种罕见但严重的COVID-19的神经并发症.

研究的目的:

在接种疫苗的个体中报告COVID-19感染后发生的髓炎病例.
为了评估血酶在治疗长期COVID-19相关髓炎中的疗效.

主要方法:

一个61岁的男性患者的病例报告,患有COVID-19后的脊髓炎.
患者经历了轻微的COVID-19感染后逐渐下肢虚弱,感官缺陷和尿路保留.
治疗涉及甲基prednisolone,然后是五个周期的血合成.

主要成果:

开始使用甲基普雷迪尼索隆的治疗没有产生临床改善.
随着血激活,患者的肌肉强度显著恢复 (从2/5到4/5).
在等离子体治疗后,感觉和尿路症状消失.

结论:

感染COVID-19可能会引发脑膜炎,即使是接种疫苗的人.
血酶似乎是长期COVID-19相关髓炎的有前途的治疗选择.
这一案例凸显了等离子体合成在治疗COVID-19严重神经系统后果方面的潜在好处.

关键词:

在 COVID-19 疫情中,骨髓炎炎是一种肌肉炎.血相结合 (plasmapheresis) 是一个过程.严重急性呼吸系统综合征新冠病毒2 类固醇类固醇是什么

更多相关视频

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin

Published on: March 26, 2015

Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis

Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis

Published on: November 17, 2020

相关概念视频

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...